Science & Technology Review
|
2017, 35(4): 31-35
• Spescial Issues •
High-risk non-disabling ischemic cerebrovascular events (HR-NICE): A new target for aggressive treatment
Full
WANG Yilong, JIA Qian, WANG Yongjun
Affiliations
Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China
Published: 2017-02-28
doi: 10.3981/j.issn.1000-7857.2017.04.004
Outline
The cerebrovascular disease is the most common cause for death or adult disability among Chinese population. The High-Risk Non-Disabling Ischemic Cerebrovascular Events (HR-NICE) are very common, and they are unstable in early phases, with good prognosis after effective treatment. In recent years, the HR-NICE has gradually attracted worldwide attentions. Our work has focused on the patients with the highest stroke risk, the most effective antithrombotic therapy, and the most appropriate individualized treatment for more than 10 years. In this paper, we review the early recognition, the diagnosis and the treatment of the HR-NICE.
cerebrovascular event
/
treatment
/
anti-thrombotic agent
王伊龙, 贾茜, 王拥军.
高危非致残性脑血管病——强化治疗的新方向.
科技导报,
2017
, 35
(4)
: 31
-35
.
DOI: 10.3981/j.issn.1000-7857.2017.04.004
WANG Yilong, JIA Qian, WANG Yongjun.
High-risk non-disabling ischemic cerebrovascular events (HR-NICE): A new target for aggressive treatment[J].
Science & Technology Review,
2017
, 35
(4)
: 31
-35
.
DOI: 10.3981/j.issn.1000-7857.2017.04.004
Year 2017 volume 35 Issue 4
PDF
508
172
Cite this Article
BibTeX
Article Info
doi: 10.3981/j.issn.1000-7857.2017.04.004
- Receive Date:2016-12-01
- Online Date:2017-02-28
- Published:2017-02-28